Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Synergistic immobilization of potentially toxic elements (PTEs) by biochar and nanoparticles in alkaline soil.

Hemati Matin N, Jalali M, Buss W.

Chemosphere. 2019 Sep 21;241:124932. doi: 10.1016/j.chemosphere.2019.124932. [Epub ahead of print]

PMID:
31590018
2.

Potassium doping increases biochar carbon sequestration potential by 45%, facilitating decoupling of carbon sequestration from soil improvement.

Mašek O, Buss W, Brownsort P, Rovere M, Tagliaferro A, Zhao L, Cao X, Xu G.

Sci Rep. 2019 Apr 2;9(1):5514. doi: 10.1038/s41598-019-41953-0.

3.

Biochar Phosphorus Release Is Limited by High pH and Excess Calcium.

Buss W, Assavavittayanon K, Shepherd JG, Heal KV, Sohi S.

J Environ Qual. 2018 Sep;47(5):1298-1303. doi: 10.2134/jeq2018.05.0181.

PMID:
30272768
4.

Standard Biochar Materials.

Mašek O, Buss W, Sohi S.

Environ Sci Technol. 2018 Sep 4;52(17):9543-9544. doi: 10.1021/acs.est.8b04053. No abstract available.

PMID:
30176731
5.

Toxicity screening of biochar-mineral composites using germination tests.

Mumme J, Getz J, Prasad M, Lüder U, Kern J, Mašek O, Buss W.

Chemosphere. 2018 Sep;207:91-100. doi: 10.1016/j.chemosphere.2018.05.042. Epub 2018 May 8.

PMID:
29778049
6.

Correction to: Influence of pyrolysis temperature and production unit on formation of selected PAHs, oxy-PAHs, N-PACs, PCDDs, and PCDFs in biochar-a screening study.

Weidemann E, Buss W, Edo M, Mašek O, Jansson S.

Environ Sci Pollut Res Int. 2018 Feb;25(4):3941-3942. doi: 10.1007/s11356-017-0804-6.

7.

Influence of pyrolysis temperature and production unit on formation of selected PAHs, oxy-PAHs, N-PACs, PCDDs, and PCDFs in biochar-a screening study.

Weidemann E, Buss W, Edo M, Mašek O, Jansson S.

Environ Sci Pollut Res Int. 2018 Feb;25(4):3933-3940. doi: 10.1007/s11356-017-0612-z. Epub 2017 Nov 8. Erratum in: Environ Sci Pollut Res Int. 2018 Jan 5;:.

8.

Barriers to enrollment in a randomized controlled trial of hydrocortisone for cardiovascular insufficiency in term and late preterm newborn infants.

Watterberg KL, Fernandez E, Walsh MC, Truog WE, Stoll BJ, Sokol GM, Kennedy KA, Fraga MV, Beauman SS, Carper B, Das A, Duncan AF, Buss WF, Gauldin C, Lacy CB, Sanchez PJ, Chawla S, Lakshminrusimha S, Cotten CM, Van Meurs KP, Poindexter BB, Bell EF, Carlo WA, Devaskar U, Wyckoff MH, Higgins RD.

J Perinatol. 2017 Nov;37(11):1220-1223. doi: 10.1038/jp.2017.131. Epub 2017 Sep 7.

9.

Bioavailability of phosphorus, other nutrients and potentially toxic elements from marginal biomass-derived biochar assessed in barley (Hordeum vulgare) growth experiments.

Shepherd JG, Buss W, Sohi SP, Heal KV.

Sci Total Environ. 2017 Apr 15;584-585:448-457. doi: 10.1016/j.scitotenv.2017.01.028. Epub 2017 Jan 26.

PMID:
28131454
10.

Standardized Treatment of Neonatal Status Epilepticus Improves Outcome.

Harris ML, Malloy KM, Lawson SN, Rose RS, Buss WF, Mietzsch U.

J Child Neurol. 2016 Dec;31(14):1546-1554. Epub 2016 Aug 31.

PMID:
27581850
11.

High-VOC biochar-effectiveness of post-treatment measures and potential health risks related to handling and storage.

Buss W, Mašek O.

Environ Sci Pollut Res Int. 2016 Oct;23(19):19580-9. doi: 10.1007/s11356-016-7112-4. Epub 2016 Jul 8.

PMID:
27392624
12.

Risks and benefits of marginal biomass-derived biochars for plant growth.

Buss W, Graham MC, Shepherd JG, Mašek O.

Sci Total Environ. 2016 Nov 1;569-570:496-506. doi: 10.1016/j.scitotenv.2016.06.129. Epub 2016 Jun 27.

PMID:
27362631
13.

Suitability of marginal biomass-derived biochars for soil amendment.

Buss W, Graham MC, Shepherd JG, Mašek O.

Sci Total Environ. 2016 Mar 15;547:314-322. doi: 10.1016/j.scitotenv.2015.11.148. Epub 2016 Jan 12.

PMID:
26789369
14.

Inherent organic compounds in biochar--Their content, composition and potential toxic effects.

Buss W, Mašek O, Graham M, Wüst D.

J Environ Manage. 2015 Jun 1;156:150-7. doi: 10.1016/j.jenvman.2015.03.035. Epub 2015 Apr 2.

PMID:
25845996
15.

Hardware architecture and cutting-edge assembly process of a tiny curved compound eye.

Viollet S, Godiot S, Leitel R, Buss W, Breugnon P, Menouni M, Juston R, Expert F, Colonnier F, L'Eplattenier G, Brückner A, Kraze F, Mallot H, Franceschini N, Pericet-Camara R, Ruffier F, Floreano D.

Sensors (Basel). 2014 Nov 17;14(11):21702-21. doi: 10.3390/s141121702.

16.

Mobile organic compounds in biochar - a potential source of contamination - phytotoxic effects on cress seed (Lepidium sativum) germination.

Buss W, Mašek O.

J Environ Manage. 2014 May 1;137:111-9. doi: 10.1016/j.jenvman.2014.01.045. Epub 2014 Mar 5.

PMID:
24608115
17.

Miniature curved artificial compound eyes.

Floreano D, Pericet-Camara R, Viollet S, Ruffier F, Brückner A, Leitel R, Buss W, Menouni M, Expert F, Juston R, Dobrzynski MK, L'Eplattenier G, Recktenwald F, Mallot HA, Franceschini N.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9267-72. doi: 10.1073/pnas.1219068110. Epub 2013 May 20.

18.

Biochar reduces copper toxicity in Chenopodium quinoa Willd. In a sandy soil.

Buss W, Kammann C, Koyro HW.

J Environ Qual. 2012 Jul-Aug;41(4):1157-65. doi: 10.2134/jeq2011.0022.

PMID:
22751058
19.

The dilemma of data-safety monitoring: provision of significant new data to research participants.

Peppercorn J, Buss WG, Fost N, Godley PA.

Lancet. 2008 Feb 9;371(9611):527-9. doi: 10.1016/S0140-6736(08)60239-1. No abstract available.

PMID:
18262043
20.

Clinical issues surrounding once-daily aminoglycoside dosing in children.

Knoderer CA, Everett JA, Buss WF.

Pharmacotherapy. 2003 Jan;23(1):44-56. Review.

PMID:
12523459
21.

EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog.

Buss WC, Stepanek J, Bankhurst AD, Mayeno AN, Pastuszyn A, Peabody D.

Autoimmunity. 1996;25(1):33-45.

PMID:
9161698
23.
24.

Changes in ATP after cyclosporin A treatment in a renal epithelial cell line in the rat studied by 31P-NMR spectroscopy.

Ruiz-Cabello J, Buss WC, Collier SW, Glazer RI, Cohen JS.

Res Commun Mol Pathol Pharmacol. 1994 Oct;86(1):3-13.

PMID:
7850254
25.

Tissue specificity of translation inhibition in Sprague-Dawley rats following in vivo cyclosporin A.

Buss WC, Stepanek J.

Int J Immunopharmacol. 1993 Aug;15(6):775-82.

PMID:
8407058
26.
27.

Energy restriction reduces metabolic rate in adult male Fisher-344 rats.

Gonzales-Pacheco DM, Buss WC, Koehler KM, Woodside WF, Alpert SS.

J Nutr. 1993 Jan;123(1):90-7.

PMID:
8421235
29.

[Fatal hepatic necrosis due to a treatment course of rheumatoid arthritis with gold salts].

Van Linthoudt D, Buss W, Beyner F, Ott H.

Schweiz Med Wochenschr. 1991 Jul 27;121(30):1099-102. Review. French.

PMID:
1678206
31.

Cyclosporine-induced renal dysfunction: correlations between cellular events and whole kidney function.

Bennett WM, Houghton DC, Buss WC.

J Am Soc Nephrol. 1991 May;1(11):1212-9.

32.

The effects of age and dosage route on experimental cyclosporine nephrotoxicity.

Bennett WM, Lindsley J, Buss WC.

Transplantation. 1991 Mar;51(3):730-1. No abstract available.

PMID:
2006533
33.

Ciclosporin and calcium: implications for drug action, interactions and toxicity.

Bennett WM, Buss WC.

Contrib Nephrol. 1991;91:50-6. Review. No abstract available.

PMID:
1800011
34.
35.

Effect of calcium channel antagonists on calcium uptake and release by isolated rat cardiac mitochondria.

Buss WC, Savage DD, Stepanek J, Little SA, McGuffee LJ.

Eur J Pharmacol. 1988 Aug 2;152(3):247-53.

PMID:
2464498
36.

Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity.

Bennett WM, Mela-Riker LM, Houghton DC, Gilbert DN, Buss WC.

Am J Physiol. 1988 Aug;255(2 Pt 2):F265-9.

PMID:
2457327
37.

Proposed mechanism of cyclosporine toxicity: inhibition of protein synthesis.

Buss WC, Stepanek J, Bennett WM.

Transplant Proc. 1988 Jun;20(3 Suppl 3):863-7. No abstract available.

PMID:
3388521
38.

Coordinate increases and decreases in mitochondrial RNA and ATP syntheses produced by propranolol and rifampicin.

Buss WC, Jaramillo E, Piatt MK.

Biochem Pharmacol. 1987 Oct 1;36(19):3293-7.

PMID:
2444231
40.

Experimental aminoglycoside nephrotoxicity.

Bennett WM, Houghton DC, Gilbert DN, Buss WC.

Dev Toxicol Environ Sci. 1986;14:3-9. No abstract available.

PMID:
3829981
41.

Toxic overdose of isoniazid, rifampicin and ethambutol.

Spalding CT, Buss WC.

Eur J Clin Pharmacol. 1986;30(3):381-2. No abstract available.

PMID:
3732380
42.

Genetic analysis of the pinna of the human ear: sex differences in college age adults.

Peeples EE, Dixon LK, Buss WR.

J Hered. 1985 Sep-Oct;76(5):390-2.

PMID:
4056373
43.
44.

Inhibitory effects of gentamicin and ethacrynic acid on mammalian microsomal protein synthesis.

Buss WC, Kauten R, Piatt MK.

J Antimicrob Chemother. 1985 Jan;15(1):105-13.

PMID:
3972753
45.

Inhibition of mammalian microsomal protein synthesis by aminoglycoside antibiotics.

Buss WC, Piatt MK, Kauten R.

J Antimicrob Chemother. 1984 Sep;14(3):231-41.

PMID:
6208181
47.

Induction of hepatic drug metabolizing enzymes and pregnancy while taking oral contraceptives.

Buss WC.

J Antimicrob Chemother. 1979 Jan;5(1):4-5. No abstract available.

PMID:
762005
48.

Stimulation of eukaryotic transcription by glycerol and polyhydroxylic compounds.

Buss WC, Stalter K.

Biochemistry. 1978 Oct 31;17(22):4825-32. No abstract available.

PMID:
728388
49.

Rifampicin inhibition of protein synthesis in mammalian cells.

Buss WC, Morgan R, Guttmann J, Barela T, Stalter K.

Science. 1978 Apr 28;200(4340):432-4.

PMID:
644307
50.

Effects of rifampicin on RNA and protein synthesis in isolated rat liver mitochondria.

Buss WC, Kun E.

Biochem Pharmacol. 1978;27(17):2139-45. No abstract available.

PMID:
728165

Supplemental Content

Support Center